Skip to main content
OpenTrials

Clinical trial condition

Stage IVA Oropharyngeal (p16-Negative) Carcinoma AJCC v8

Explore clinical trials studying Stage IVA Oropharyngeal (p16-Negative) Carcinoma AJCC v8. Study availability and eligibility vary by location and protocol.

12 public trials 8 recruiting studies
Refine in advanced search Browse all conditions

Stage IVA Oropharyngeal (p16-Negative) Carcinoma AJCC v8 trial results

Completed

Radiation Therapy With Durvalumab or Cetuximab in Treating Patients With Locoregionally Advanced Head and Neck Cancer Who Cannot Take Cisplatin

NCT03258554

Conditions
Carcinoma, Carcinoma, Squamous Cell, Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, +38 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • CTCA at Western Regional Medical Center Goodyear, Arizona, United States
View all 256 locations
View Trial Details

Related conditions